JB Chemicals reports Q4 FY26 results with ₹904 crore revenue, ₹241 crore EBITDA, and ₹101 crore PAT; full-year FY26 revenue ₹4,148 crore with India growth of 9% and BGx up 11%, on track for a recovery in H1 FY27.
AI Assistant
J B Chemicals & Pharmaceuticals Ltd
2026
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.